Omicron infection may increase risk of reinfection, study finds

Researchers at McMaster University have found that rather than conferring immunity against future infections, infection during the first Omicron wave of COVID left the seniors they studied much more vulnerable to reinfection during the second Omicron wave.

Drug-Resistant Bacteria Deaths Projected to Rise 70% by 2050

Antimicrobial-resistant bacterial infections directly caused more than 1 million deaths worldwide annually from 1990 to 2021, and that number is projected to increase by almost

September 17, 2024

MindBio Reports Promising Phase 2A Results for Depression Treatment with LSD | Psychedelic Invest

MindBio Therapeutics Corp. (CSE) has recently unveiled promising durability data from its Phase 2A clinical trials, which tested MB22001, the company’s innovative self-administered, take-home microdose

August 19, 2024

Backed by $15m in NIDA Funding, NYU and B.More Team Up to Trial Psilocybin for Opioid Use Disorder – Psychedelic Alpha

The double-blind, multi-site randomised controlled trial will evaluate psilocybin’s potential in reducing opioid cravings and improving emotional well-being in individuals struggling with OUD but who

October 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.